Fmc Corporation · NYSE:FMC
Fmc — Butz Bank of America Conference Call (November 2004)
11 slides from Fmc's conference presentation, Nov 12, 2004
Slide 1: FMC Corporation Conference Call
Exhibit 99.1 FMCButz Bank November Ted Vice President of Corporation America 12, 2004 andConference Group Manager, Call Specialty Chemicals
Slide 2: Safe Harbor Statement Disclaimer
SafeCompany Disclaimer These Actual Additional Securities The 1 Harbor slides results Exchange information Statement and of undertakes the Act Company accompanying under concerning ofno1934, obligation the may Private asfactors presentation differ amended. toSecurities materially update that may con
Slide 3: Use of Non-GAAP Terms
Use ofslides These addition, principle EBITDA change Segment 2 Non-GAAP inEBITDA at and (Earnings Margin accounting the contain Depreciation end isMargin (Earnings Terms of the Before certain principle this quotient presentation, is and Interest, “non-GAAP the Before for Amortization. of quotient th
Slide 4: FMC Corporation: Diversified Chemical Company
Diversified ($ FMC Industrial Agricultural Specialty Sales: EBITDA: Margin: 3 million, Corporation $2,053.4 $809.6 $713.3 $535.6 17.7% 13.9% 21.0% 24.4% Chemicals Chemicals $362.7 $112.6 $149.6 $130.6 LTM chemical Products 9/30/04) company with leading market positions in industrial, consumer and ag
Slide 5: Specialty Chemicals Overview
Specialty LTM* $535.6 $’s, 2004* 2003 2002 Margin, 30% 25% 20% 15% 10% 5% 0% Capital EBITDA 2 0 $131 $132 $116 * 29% Lithium 71% BioPolymer 140 120 100 80 60 40 BioPolymer: — Lithium: 4 0Last Acts millions twelve Sales: million Spending as % —Margin Chemicals a Focus binder — months, Adds (%)on &Ove
Slide 6: FMC BioPolymer: Balanced Portfolio
FMC LTM* Balanced Personal Leading Pharmaceutical 9% Industrial 42% Food 7% Alginates Excellent 51% Cellulose 33% Carrageenan 17% North Latin 32% Europe 45% Employees 10% Asia 13% Manufacturing Technical * 5 LastAmerica BioPolymer America twelve 2004 Positions Care Portfolio Global & Labs 900 Sales:
Slide 7: FMC BioPolymer Market Leadership
Strength Market Alginates Carrageenan FMC MCC Share Leadership 6 BioPolymer Position: Size in All Scale: (M): Core # 1$235 5.5 Market #Product 1X#$335 2.2 2Positions XAreas $185 0.95X
Slide 8: FMC BioPolymer's Strong Outlook
FMC BioPolymer’s Serving Strong Leading Coordinated Proven 7 position track attractive product global record with positions end capabilities of Outlook industry-driving markets performance is Positive customers
Slide 9: FMC Corporation
FiviC FMC Corporation
Slide 10: Non-GAAP Reconciliation
Non-GAAP Reconciliation (Unaudited, [As Income LTM Restructuring Add: Interest Affiliate Depreciation EBITDA 9 of November (loss) expense, Interest (Non-GAAP) to inand and from GAAP millions) ofExpense net amortization last 12, other continuing 81.4 2004] twelve Reconciliations 362.7 charges 3.3mont
Slide 11: Non-GAAP Reconciliation (Cont.)
Non-GAAP Reconciliation (Unaudited, [As Segment Depreciation Add: LTM 10 ofEBITDA segment November Industrial to inand operating GAAP millions) of (Non-GAAP) amortization last 12, Chemicals 2004] twelve Reconciliations profitmonths $112.6 Specialty (GAAP) 64.9 31.8 $130.6 (LTM) (Cont.) $47.7 Chemica
FMC — Butz Bank of America Conference Call (November 2004) on 6ix